Volume 94 Issue 6 | pp. 18-19
Issue Date: February 8, 2016

How China Is Improving The Drug Approval Process

Expectations are high in the country’s pharmaceutical industry that access to a huge market will become easier
Department: Business
Keywords: China, pharmaceutical, patents, drug approval, biotech, CFDA, SFDA

When Zhejiang Pharmaceutical Association organized a conference on Chinese drug approval reforms in Hangzhou, China, participation was strong. About 500 people, mostly from drug firms operating in the province, attended the one-day event in December.

“Our objective is to have a response rate faster than foreign regulatory agencies such as the U.S. FDA,” Jiaxi Xu, director of the Center for Drug Evaluation at the China Food & Drug Administration . . .

To view the rest of this content, please log in with your ACS ID.



 
Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society